A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

NCT01610687 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
137
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jazz Pharmaceuticals